Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Wang, Yi-cheng"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia.
Autorzy:
Huang BJ; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA. .; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. .
Smith JL; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Farrar JE; University of Arkansas for Medical Sciences & Arkansas Children's Research Institute, Little Rock, AR, USA.
Wang YC; Children's Oncology Group, Monrovia, CA, USA.
Umeda M; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ries RE; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Leonti AR; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Crowgey E; Nemours Center for Cancer and Blood Disorders and Alfred I. DuPont Hospital for Children, Wilmington, DE, USA.
Furlan SN; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Tarlock K; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Armendariz M; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Liu Y; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Shaw TI; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Wei L; Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
Gerbing RB; Children's Oncology Group, Monrovia, CA, USA.
Cooper TM; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Gamis AS; Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Aplenc R; Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kolb EA; Nemours Center for Cancer and Blood Disorders and Alfred I. DuPont Hospital for Children, Wilmington, DE, USA.
Rubnitz J; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ma J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Klco JM; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ma X; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Alonzo TA; Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
Triche T Jr; Van Andel Research Institute, Grand Rapids, MI, USA.
Meshinchi S; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Sep 19; Vol. 13 (1), pp. 5487. Date of Electronic Publication: 2022 Sep 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Expression Profiling*
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/genetics
Biomarkers ; Child ; Humans ; Neoplastic Stem Cells ; RNA ; Recurrence
Czasopismo naukowe
Tytuł:
ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial.
Autorzy:
Rafiee R; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Chauhan L; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Wang YC; Children's Oncology Group, Monrovia, CA, USA.
Elmasry A; Mansoura University, Mansoura, Egypt.
Loken MR; Hematologics Inc, Seattle, USA.
Pollard J; Dana-Farber/Boston Children's Cancer Center and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Aplenc R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Raimondi S; Department of Pathology, St. Jude Children's Hospital, Memphis, TN, USA.
Hirsch BA; Children's Hospitals and Clinic of Minnesota, University of Minnesota, Minneapolis, MN, USA.
Bernstein ID; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Gamis AS; Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Lamba JK; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA. .
Pokaż więcej
Źródło:
Blood cancer journal [Blood Cancer J] 2019 May 21; Vol. 9 (6), pp. 51. Date of Electronic Publication: 2019 May 21.
Typ publikacji:
Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*
Polymorphism, Single Nucleotide*
Antineoplastic Agents, Immunological/*therapeutic use
Gemtuzumab/*therapeutic use
Leukemia, Myeloid, Acute/*drug therapy
Leukemia, Myeloid, Acute/*genetics
ATP Binding Cassette Transporter, Subfamily B/genetics ; Adolescent ; Adult ; Alleles ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Child ; Child, Preschool ; Female ; Gemtuzumab/administration & dosage ; Gemtuzumab/adverse effects ; Genotype ; Humans ; Infant ; Infant, Newborn ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/mortality ; Male ; Prognosis ; Recurrence ; Treatment Outcome ; Young Adult
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies